Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

Vergote, I.; Van Nieuwenhuysen, E.; Casado, A.; Laenen, A.; Lorusso, D.; Braicu, E. I.; Guerra-Alia, E.; Zola, P.; Wimberger, P.; Debruyne, P. R.; Falcó, E.; Ferrero, A.; Muallem, M. Z.; Kerger, J.; García-Martinez, E.; Pignata, S.; Sehouli, J.; Van Gorp, T.; Gennigens, C.; Rubio, M. J.